Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 11 articles:
HTML format
Text format



Single Articles


    September 2015
  1. WARRILLOW S, Moran J, Weickhardt A
    Advanced Dementia.
    N Engl J Med. 2015;373:1276.
    PubMed     Text format    


  2. JENKINS I
    Advanced Dementia.
    N Engl J Med. 2015;373:1275-6.
    PubMed     Text format    


  3. MITCHELL SL
    Advanced Dementia.
    N Engl J Med. 2015;373:1276-7.
    PubMed     Text format    


    July 2015
  4. LANDER ES
    Brave New Genome.
    N Engl J Med. 2015;373:5-8.
    PubMed     Text format    


    June 2015
  5. TANZI RE
    TREM2 and Risk of Alzheimer's Disease - Friend or Foe?
    N Engl J Med. 2015;372:2564-5.
    PubMed     Text format     Abstract available


  6. MITCHELL SL
    CLINICAL PRACTICE. Advanced Dementia.
    N Engl J Med. 2015;372:2533-40.
    PubMed     Text format    


    April 2014
  7. DE LA TORRE JC
    Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease.
    N Engl J Med. 2014;370:1459-60.
    PubMed     Text format    


  8. LASKE C
    Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease.
    N Engl J Med. 2014;370:1459.
    PubMed     Text format    


  9. DOODY RS, Farlow M, Aisen PS
    Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease.
    N Engl J Med. 2014;370:1460.
    PubMed     Text format    


  10. SALLOWAY S, Sperling R, Brashear HR
    Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease.
    N Engl J Med. 2014;370:1460.
    PubMed     Text format    


    February 2014
  11. WUNDERINK RG, Waterer GW
    Clinical practice. Community-acquired pneumonia.
    N Engl J Med. 2014;370:543-51.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: